These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24876772)

  • 41. A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®.
    Seth A; Katti DS
    Int J Nanomedicine; 2012; 7():5129-36. PubMed ID: 23055725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.
    Prabha S; Labhasetwar V
    Pharm Res; 2004 Feb; 21(2):354-64. PubMed ID: 15032319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and properties of nanosized biodegradable polymer capsules.
    Sakai H; Sekita A; Tanaka K; Sakai K; Kondo T; Abe M
    J Oleo Sci; 2011; 60(11):569-73. PubMed ID: 22027022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs.
    Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW
    Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of gene delivery system using PLGA nanospheres].
    Tahara K; Yamamoto H; Takeuchi H; Kawashima Y
    Yakugaku Zasshi; 2007 Oct; 127(10):1541-8. PubMed ID: 17917416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS; Kim CS; Lee KM
    Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and characterization of GRGDSPC-modified poly(lactide-co-glycolide acid) porous microspheres incorporated with protein-loaded chitosan microspheres for bone tissue engineering.
    Tao C; Huang J; Lu Y; Zou H; He X; Chen Y; Zhong Y
    Colloids Surf B Biointerfaces; 2014 Oct; 122():439-446. PubMed ID: 25074502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
    Wang Y; Li P; Kong L
    AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient gene delivery system mediated by cis-aconitate-modified chitosan-g-stearic acid micelles.
    Yao JJ; Du YZ; Yuan H; You J; Hu FQ
    Int J Nanomedicine; 2014; 9():2993-3003. PubMed ID: 24971010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis.
    Samdancioglu S; Calis S; Sumnu M; Atilla Hincal A
    Drug Dev Ind Pharm; 2006 Apr; 32(4):473-81. PubMed ID: 16638686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
    Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
    Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.
    Chen M; Gao S; Dong M; Song J; Yang C; Howard KA; Kjems J; Besenbacher F
    ACS Nano; 2012 Jun; 6(6):4835-44. PubMed ID: 22621383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfection activity of layer-by-layer plasmid DNA/poly(ethylenimine) films deposited on PLGA microparticles.
    Kakade S; Manickam DS; Handa H; Mao G; Oupický D
    Int J Pharm; 2009 Jan; 365(1-2):44-52. PubMed ID: 18786622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
    Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.